Skip to main content
Erschienen in: Neurological Sciences 8/2022

06.04.2022 | Original Article

Risk factors for motor complications in female patients with Parkinson’s disease

verfasst von: Zhirong Wan, Xuemei Wang, Huizi Ma, Zhan Wang, Tao Feng

Erschienen in: Neurological Sciences | Ausgabe 8/2022

Einloggen, um Zugang zu erhalten

Abstract

Objective

To investigate the risk factors of motor complications in female patients with Parkinson’s disease (PD) and the correlation between the occurrence of motor complications and sex hormone levels.

Methods

According to the occurrence and types of motor complications, 103 female PD patients were divided into two groups: patients with or without the wearing-off phenomenon, patients with or without dyskinesia. Binary logistic regression analysis was performed respectively to screen for the risk factors of the wearing-off phenomenon and dyskinesia in female PD patients.

Results

Among 103 female PD patients, 44 (42.72%) had motor complications. Patients with the wearing-off phenomenon and patients with dyskinesia had higher prolactin levels than patients without the wearing-off phenomenon and patients without dyskinesia, respectively. However, the difference was no longer significant when the two groups were corrected for multiple comparisons (P < 0.0028). Multivariate analysis found that younger age at onset and higher Hoehn-Yahr (H&Y) stage were identified as independent risk factors for the wearing-off phenomenon and younger age of onset was an independent risk factor for dyskinesia in female PD patients (P < 0.05).

Conclusion

Female PD patients have a higher incidence of motor complications. Younger age of onset and higher H&Y stage were the risk factors of the wearing-off phenomenon, and younger onset age was the risk factor of dyskinesia in female PD patients. There may be a certain correlation between the occurrence of motor complications and sex hormone levels in female PD patients, which requires further verification.
Literatur
4.
Zurück zum Zitat Dali W, Zhengqin S, Rui H, Fucheng Q, Hongxu C, Ping G (2016) Study on motor complications in patients with Parkinson’s disease. Chin J Coal Ind Med 19(12):1693–1696 Dali W, Zhengqin S, Rui H, Fucheng Q, Hongxu C, Ping G (2016) Study on motor complications in patients with Parkinson’s disease. Chin J Coal Ind Med 19(12):1693–1696
5.
Zurück zum Zitat Huiqing Z, Genliang L, Yanying S, Zhan W (2019) The relationship between endogenous estrogen levels and non-motor symptoms in postmenopausal Parkinson’s disease patients. Chin J Fam Plan 27(08):1083–1086 Huiqing Z, Genliang L, Yanying S, Zhan W (2019) The relationship between endogenous estrogen levels and non-motor symptoms in postmenopausal Parkinson’s disease patients. Chin J Fam Plan 27(08):1083–1086
6.
Zurück zum Zitat Yueqi Z, Gang W (2016) Introduction of the new criteria for clinical diagnosis of Parkinson’s disease of the International Movement Disorders Association (2015). J Diagn Concepts Pract 15(02):122–123 Yueqi Z, Gang W (2016) Introduction of the new criteria for clinical diagnosis of Parkinson’s disease of the International Movement Disorders Association (2015). J Diagn Concepts Pract 15(02):122–123
7.
Zurück zum Zitat Hongwei Q, Wan Ying Hu, Yingying CZ, Na Wu, Jing G, Zhenguo L (2019) Analysis of clinical characteristics of the wearing-off phenomenon in Parkinson’s disease. Chin J Clin Neurosci 27(04):395–404 Hongwei Q, Wan Ying Hu, Yingying CZ, Na Wu, Jing G, Zhenguo L (2019) Analysis of clinical characteristics of the wearing-off phenomenon in Parkinson’s disease. Chin J Clin Neurosci 27(04):395–404
8.
Zurück zum Zitat Guoyong Z, Zhang Yu, Aijuan Y et al (2018) Research progress on the risk factors, diagnosis and treatment of Parkinson’s disease dyskinesia. Chin J Neurol 51(12):1002–1007 Guoyong Z, Zhang Yu, Aijuan Y et al (2018) Research progress on the risk factors, diagnosis and treatment of Parkinson’s disease dyskinesia. Chin J Neurol 51(12):1002–1007
12.
Zurück zum Zitat Jinli Z (2017) Clinical observation of 37 cases of Parkinson’s disease treated with levodopa/benserazide. Contemp Med 23(04):68–69 Jinli Z (2017) Clinical observation of 37 cases of Parkinson’s disease treated with levodopa/benserazide. Contemp Med 23(04):68–69
13.
Zurück zum Zitat Xue B, Yuping J (2017) Treatment of levodopa peak dose dyskinesia in Parkinson’s disease. Chin J Clin Neurosci 25(03):301–305 Xue B, Yuping J (2017) Treatment of levodopa peak dose dyskinesia in Parkinson’s disease. Chin J Clin Neurosci 25(03):301–305
14.
Zurück zum Zitat Jing T, Xiaoguang L (2019) Factors associated with levodopa-induced wearing-off phenomenon in Parkinson’s disease. J Int Neurol Neurosurg 46(04):387–390 Jing T, Xiaoguang L (2019) Factors associated with levodopa-induced wearing-off phenomenon in Parkinson’s disease. J Int Neurol Neurosurg 46(04):387–390
15.
Zurück zum Zitat Zhirong W, Zhang Yu, Gao Jing Su, Dongning SM, Tao F (2017) Analysis of related factors affecting menstrual period in female Parkinson’s disease patients. J Clin Neurol 30(03):200–203 Zhirong W, Zhang Yu, Gao Jing Su, Dongning SM, Tao F (2017) Analysis of related factors affecting menstrual period in female Parkinson’s disease patients. J Clin Neurol 30(03):200–203
16.
Zurück zum Zitat Yanru Ma, Rui G, Hongyan R (2017) Progress in the treatment of motor complications of Parkinson’s disease. Orient Diet Health Care 4(10):317–317 Yanru Ma, Rui G, Hongyan R (2017) Progress in the treatment of motor complications of Parkinson’s disease. Orient Diet Health Care 4(10):317–317
18.
Zurück zum Zitat Zhang Lu, Yujun P (2017) Overview of the complications induced by levodopa of Parkinson’s disease. Stroke Neurol Dis 24(6):571–573 Zhang Lu, Yujun P (2017) Overview of the complications induced by levodopa of Parkinson’s disease. Stroke Neurol Dis 24(6):571–573
19.
Zurück zum Zitat Xiao W, Jingjing Z (2020) Research progress on estrogen and cognitive impairment-dementia. Neurol Dis Mental Health 20(7):490–493 Xiao W, Jingjing Z (2020) Research progress on estrogen and cognitive impairment-dementia. Neurol Dis Mental Health 20(7):490–493
20.
Zurück zum Zitat Warren OC, Kieburtz K, Rascol O, Poewe W, Schapira AH, Emre M, Nissinen H, Leinonen M, Stocchi F (2013) Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson’s disease. Mov Disord 28(8):1064–1071. https://doi.org/10.1002/mds.25364CrossRef Warren OC, Kieburtz K, Rascol O, Poewe W, Schapira AH, Emre M, Nissinen H, Leinonen M, Stocchi F (2013) Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson’s disease. Mov Disord 28(8):1064–1071. https://​doi.​org/​10.​1002/​mds.​25364CrossRef
21.
Zurück zum Zitat Tu Li (2017) Analysis of clinical characteristics of patients with Parkinson’s disease. Guizhou Medical University Tu Li (2017) Analysis of clinical characteristics of patients with Parkinson’s disease. Guizhou Medical University
Metadaten
Titel
Risk factors for motor complications in female patients with Parkinson’s disease
verfasst von
Zhirong Wan
Xuemei Wang
Huizi Ma
Zhan Wang
Tao Feng
Publikationsdatum
06.04.2022
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 8/2022
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-022-05959-3

Weitere Artikel der Ausgabe 8/2022

Neurological Sciences 8/2022 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.